The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, collectively known as America’s Seed Fund, are central to the federal innovation ecosystem. These programs have delivered over $70 billion in R&D funding to more than 30,000 small businesses, generating an estimated $22 to $33 of private investment for every federal dollar spent.
Despite this high return on investment, the statutory authority for both programs lapsed on October 1, 2025, halting new activity across the 11 federal agencies mandated to participate. The failure to reauthorize stems from a push for a comprehensive reform, as policymakers used the expiration deadline as leverage to force systemic changes focused on strengthening accountability and transition metrics.
Historical Foundation and Program Mechanics
The SBIR program was established by Congress in 1982 through the Small Business Innovation Development Act to address U.S. competitiveness concerns, aiming to stimulate innovation, meet federal R&D needs, and increase private sector commercialization. The complementary STTR program was established in 1992 to specifically stimulate innovation through mandatory cooperative R&D between small business concerns (SBCs) and non-profit research institutions (RIs). Both programs operate under a “sunset provision,” requiring periodic congressional reauthorization to remain active.
The latest comprehensive reauthorization of both the SBIR and STTR programs occurred in 2016. It was included as part of the 2017 National Defense Authorization Act (NDAA).
The measure was a simple five-year reauthorization, which set the new program expiration date for September 30, 2022. This specific reauthorization involved no allocation increase or new pilot programs. The National Defense Authorization Act for Fiscal Year 2019 (signed August 13, 2018) separately extended four existing pilot authorities through Fiscal Year 2022 (FY22).
On September 30, 2022 President Biden signed the SBIR and STTR Extension Act of 2022, which renewed the SBIR, STTR, and six related pilot programs for three additional years, through September 30, 2025.
While the House of Representatives has now passed H.R. 5100, a simple, 1-year extension of SBIR/STTR through September 30, 2026, with no programmatic changes; competing proposals are blocking it from reaching consensus in the Senate.
The SBIR/STTR Reauthorization Act of 2025 is emerging as one of the main proposals and likely the one with the most momentum. It brings in a set of consistent changes designed to strengthen commercialization and broaden access for applicants.
Analysis of the SBIR/STTR Reauthorization Act of 2025
The SBIR/STTR Reauthorization Act of 2025 (S.1573 / H.R. 3169) seeks to make the programs permanent while dramatically scaling their operational scope.
The Act’s most fundamental provision is the permanent authorization of both programs. This provides the legislative certainty necessary for small businesses to plan long-term, high-risk R&D strategies and ensures a stable pipeline for federal agencies.
The Historic Funding Overhaul (The 7% Mandate)
The proposed legislation introduces a significant overhaul of federal R&D funding by gradually increasing the mandatory set-asides for the SBIR and STTR programs over seven years. Under the new mandate, the SBIR allocation would rise from the current minimum of 3.2% of an agency’s extramural R&D budget to at least 7%, while the STTR allocation would increase from 0.45% to at least 1%. This change would require participating agencies to more than double SBIR and STTR funding, ultimately channeling billions more in R&D resources to small businesses and strengthening the overall efficiency and impact of federal research investments.
Enhancing Commercialization and Transition Success
To bridge the “valley of death” (where Phase II technologies fail to commercialize), the Act mandates systemic reforms :
- Technology Commercialization Official (TCO): Agencies must designate a TCO to streamline the transition of funded technologies into federal programs or commercial markets.
- Acquisition Training: Mandating acquisition training improves the government’s capacity to identify, evaluate, and procure these small business innovations.
These requirements shift the responsibility for commercial success onto the federal bureaucracy, maximizing the utility of the government’s investment.
Broadening Participation and Security
The bill includes critical measures designed to diversify the applicant pool and lower resource barriers for new participants. It proposes to reauthorize the Federal and State Technology (FAST) Partnership Program to increase proposal success and commercialization readiness, especially in historically underrepresented states.
The Act also permits the establishment of internship and fellowship opportunities using SBIR/STTR funds, with a specific, targeted effort to reach women and socially and economically disadvantaged individuals (SEDI). Furthermore, the legislation extends bipartisan foreign due diligence efforts until 2030 for national security protections.
Conclusion
The current lapse of the SBIR/STTR program creates a pause in activity that may slow ongoing innovation efforts. Prompt reauthorization would help maintain stability for small businesses engaged in federal R&D. The proposed SBIR/STTR Reauthorization Act of 2025 outlines several updates to the program, including expanded commercialization support and participation pathways, though the overall effect will depend on future implementation. In the near term, ensuring a timely renewal remains important to avoid further disruption across the U.S. innovation landscape.